Regeneron (REGN) Tops Q1 EPS by 53c

Regeneron (NASDAQ: REGN) reported Q1 EPS of $10.09, $0.53 better than the analyst estimate of $9.56. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Revelation Biosciences (REVB) Misses Q2 EPS by 4c
• King Pharmaceuticals (KG) Misses Q2 EPS by 103c